What is NDC 68462-110?

68462-110 is the product NDC for Topiramate, Topiramate 200 mg/1 tablet, film coated, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 3 package NDCs, shown above in 10- and 11-digit form.

Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Topiramate?

277 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Topiramate NDC 68462-110 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-110-05	6846201100568462011005	500 TABLET, FILM COATED in 1 BOTTLE (68462-110-05)Marketed from Jul 30, 2020
68462-110-10	6846201101068462011010	1000 TABLET, FILM COATED in 1 BOTTLE (68462-110-10)Marketed from Mar 27, 2009
68462-110-60	6846201106068462011060	60 TABLET, FILM COATED in 1 BOTTLE (68462-110-60)Marketed from Mar 27, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Topiramate
Generic name (nonproprietary): topiramate
Active ingredients: Topiramate — 200 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077627
Marketing start: Mar 27, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68462-110_c6569dc4-2be9-48f4-8e03-6da27ac996b0SPL ID c6569dc4-2be9-48f4-8e03-6da27ac996b0SPL set ID 35312f49-decf-428d-bf5f-4215b762ed3cRxCUI 151226, 199888, 199889, 199890UNII 0H73WJJ391UPC 0368462109601, 0368462153604, 0368462110607

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462011005 followed by a unit qualifier and the quantity

Package 68462-0110-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 10, 2026.

Indications (excerpt from the label)

Topiramate tablets are indicated for: • Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 ); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2 ) • Preventive treatment of migraine in patients 12 years of age and older ( 1.3 ) 1.1 Monotherapy Epilepsy Topiramate tablets are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic‑clonic seizures in patients 2 years of age and older. 1.2 Adjunctive Thera…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68462-110

What is NDC 68462-110?: 68462-110 is the product NDC for Topiramate, Topiramate 200 mg/1 tablet, film coated, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Topiramate.
What is the active ingredient?: Topiramate.
Who is the labeler?: Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Topiramate?: 277 other product NDCs are listed under this name. See all Topiramate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Topiramate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-325	27808-0325-01
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-326	27808-0326-01
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-327	27808-0327-01
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-328	27808-0328-01
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-329	27808-0329-01
topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-952	60760-0952-60
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0357	67046-0357-03
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1691	67046-1691-03
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-079	87441-0079-01
Topiramate	Topiramate 100 mg/1	TabletOral	Coupler LLC	67046-1688	67046-1688-03

All 278 Topiramate NDCs

Other NDCs under ANDA 077627

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077627
Product	Strength	Form · route	Labeler	Product NDC
Topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-2955
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-079
Topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-283
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Glenmark Pharmaceuticals Inc., USA	68462-108
Topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Northwind Health Company, LLC	51655-608
Topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Glenmark Pharmaceuticals Inc., USA	68462-109
Topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	Glenmark Pharmaceuticals Inc., USA	68462-153
Topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4340
Topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-479
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-118